TCRT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alaunos Therapeutics Inc (TCRT) is not a good buy for a beginner investor with a long-term strategy at this time. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or analyst support. The technical indicators do not suggest a favorable entry point, and the absence of recent news or influential trades further diminishes its appeal.
The MACD is negative and expanding, suggesting bearish momentum. RSI is at 28.856, indicating the stock is approaching oversold territory but not yet a strong buy signal. Moving averages are converging, showing no clear trend. Key support is at 2.953, and resistance is at 3.4, with the current pre-market price at 3.01, near support levels.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data available.
Weak financial performance with negative net income and declining EPS (-24.29% YoY). The stock has a 70% probability of declining in the next week and month based on candlestick pattern analysis.
In 2025/Q3, revenue remained at 0 with no YoY growth. Net income improved slightly to -1,159,000 (up 2.84% YoY), but EPS dropped significantly by -24.29% YoY to -0.53. Gross margin remains at 100%, but the lack of revenue growth and profitability is concerning.
No recent analyst ratings or price target changes available.
